Clearance of Amyloid-β peptide across the choroid plexus in alzheimer's disease

Current Aging Science

Volumn 3, Issue 3, 2010, Pages 219-229

  Alvira Botero, Ximena ^a,b   Carro, Eva M ^b,c  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

Aging; Alzheimer's disease; Amyloid beta; Choroid plexus; Epithelial cells; Megalin; Tight junctions; Vesicular transport proteins

Indexed keywords

ADRENOMEDULLIN; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ARGININE; BASIC FIBROBLAST GROWTH FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CLUSTERIN; ENDOTHELIN 1; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; MEGALIN; NERVE GROWTH FACTOR; NEUROTROPHIN 3; NEUROTROPHIN 4; PREALBUMIN; PROSTAGLANDIN D SYNTHASE; SCATTER FACTOR; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 6; TRANSFERRIN; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULOTROPIN; VASOPRESSIN;

AGING; ALZHEIMER DISEASE; ATHEROSCLEROSIS; BETA RHYTHM; BLOOD CEREBROSPINAL FLUID BARRIER; BRAIN DAMAGE; BRAIN DYSFUNCTION; BRAIN FUNCTION; CHO CELL; CHOROID PLEXUS; DEGENERATIVE DISEASE; DEMENTIA; HEART DISEASE; HUMAN; HYPERTENSION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; REVIEW; STROKE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BLOOD-BRAIN BARRIER; CHOROID PLEXUS; DISEASE PROGRESSION; HUMANS; LDL-RECEPTOR RELATED PROTEIN 2;

EID: 78651273605     PISSN: 18746098     EISSN: 18746128     Source Type: Journal    
DOI: 10.2174/1874609811003030219     Document Type: Review

References (102)

1. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease:progress and problems on the road to therapeutics. Science 2002; 297(5580): 353-6.
2. Tanzi RE, Moir RD, Wagner SL. Clearance of Alzheimer's Abetapeptide: the many roads to perdition. Neuron 2004; 43(5): 605-8.
3. Gentile MT, Vecchione C, Maffei A, Aretini A, Marino G, Poulet R, et al. Mechanisms of soluble beta-amyloid impairment of endothelialfunction. J Biol Chem 2004; 279(46): 48135-42.
4. Hof PR, Morrison JH. The aging brain: morphomolecular senescenceof cortical circuits. Trends Neurosci 2004; 27(10): 607-13.
5. Zlokovic BV. Clearing amyloid through the blood-brain barrier. JNeurochem 2004; 89(4): 807-11.
6. Davis J, Xu F, Deane R, Romanov G, Previti ML, Zeigler K, et al. Early-onset and robust cerebral microvascular accumulation ofamyloid beta-protein in transgenic mice expressing low levels of avasculotropic Dutch/Iowa mutant form of amyloid beta-proteinprecursor. J Biol Chem 2004; 279(19): 20296-306.
7. Deane R, Wu Z, Zlokovic BV. RAGE (yin) versus LRP (yang)balance regulates alzheimer amyloid beta-peptide clearance throughtransport across the blood-brain barrier. Stroke 2004; 35(11 Suppl 1): 2628-31.
8. Carro E, Spuch C, Trejo JL, Antequera D, Torres-Aleman I. Choroidplexus megalin is involved in neuroprotection by serum insulinlikegrowth factor I. J Neurosci 2005; 25(47): 10884-93.
9. Zlokovic BV, Martel CL, Matsubara E, McComb JG, Zheng G, McCluskey RT, et al. Glycoprotein 330/megalin: probable role inreceptor-mediated transport of apolipoprotein J alone and in a complexwith Alzheimer disease amyloid beta at the blood-brain andblood-cerebrospinal fluid barriers. Proc Natl Acad Sci USA 1996; 93(9): 4229-34.
10. Hammad SM, Ranganathan S, Loukinova E, Twal WO, Argraves WS. Interaction of apolipoprotein J-amyloid beta-peptide complexwith low density lipoprotein receptor-related protein-2/megalin. Amechanism to prevent pathological accumulation of amyloid betapeptide. J Biol Chem 1997; 272(30): 18644-9.
11. Serot JM, Bene MC, Faure GC. Choroid plexus, aging of the brain, and Alzheimer's disease. Front Biosci 2003; 8: s515-21.
12. Preston JE. Ageing choroid plexus-cerebrospinal fluid system. Microsc Res Tech 2001; 52(1): 31-7.
13. Chodobski A, Szmydynger-Chodobska J. Choroid plexus: target forpolypeptides and site of their synthesis. Microsc Res Tech 2001; 52(1): 65-82.
14. Li Y, Chen J, Chopp M. Cell proliferation and differentiation fromependymal, subependymal and choroid plexus cells in response tostroke in rats. J Neurol Sci 2002; 193(2): 137-46.
15. Ide C, Kitada M, Chakrabortty S, Taketomi M, Matsumoto N, Kikukawa S, et al. Grafting of choroid plexus ependymal cellspromotes the growth of regenerating axons in the dorsal funiculusof rat spinal cord: a preliminary report. Exp Neurol 2001; 167(2): 242-51.
16. Dohrmann GJ. The choroid plexus: a historical review. Brain Res 1970; 18(2): 197-218.
17. Dohrmann GJ, Bucy PC. Human choroid plexus: a light and electronmicroscopic study. J Neurosurg 1970; 33(5): 506-16.
18. Keep RF, Jones HC. A morphometric study on the development ofthe lateral ventricle choroid plexus, choroid plexus capillaries andventricular ependyma in the rat. Brain Res Dev Brain Res 1990; 56(1): 47-53.
19. Cornford EM, Varesi JB, Hyman S, Damian RT, Raleigh MJ. Mitochondrial content of choroid plexus epithelium. Exp Brain Res 1997; 116(3): 399-405.
20. Dziegielewska KM, Ek J, Habgood MD, Saunders NR. Developmentof the choroid plexus. Microsc Res Tech 2001; 52(1): 5-20.
21. Speake T, Whitwell C, Kajita H, Majid A, Brown PD. Mechanismsof CSF secretion by the choroid plexus. Microsc Res Tech 2001; 52(1): 49-59.
22. Oshio K, Song Y, Verkman AS, Manley GT. Aquaporin-1 deletionreduces osmotic water permeability and cerebrospinal fluid production. Acta Neurochir Suppl 2003; 86: 525-8.
23. Reiber H. Dynamics of brain-derived proteins in cerebrospinalfluid. Clin Chim Acta 2001; 310(2): 173-86.
24. Aldred AR, Brack CM, Schreiber G. The cerebral expression ofplasma protein genes in different species. Comp Biochem PhysiolB Biochem Mol Biol 1995; 111(1): 1-15.
25. Stopa EG, Berzin TM, Kim S, Song P, Kuo-LeBlanc V, Rodriguez-Wolf M, et al. Human choroid plexus growth factors: What are theimplications for CSF dynamics in Alzheimer's disease? Exp Neurol 2001; 167(1): 40-7.
26. Mufson EJ, Kroin JS, Sendera TJ, Sobreviela T. Distribution andretrograde transport of trophic factors in the central nervous system:functional implications for the treatment of neurodegenerativediseases. Prog Neurobiol 1999; 57(4): 451-84.
27. Borlongan CV, Thanos CG, Skinner SJ, Geaney M, Emerich DF. Transplants of encapsulated rat choroid plexus cells exert neuroprotectionin a rodent model of Huntington's disease. Cell Transplant 2008; 16(10): 987-92.
28. Emerich DF, Borlongan CV. Potential of choroid plexus epithelialcell grafts for neuroprotection in Huntington's disease: what remainsbefore considering clinical trials. Neurotox Res 2009; 15(3): 205-11.
29. Hakvoort A, Haselbach M, Wegener J, Hoheisel D, Galla HJ. Thepolarity of choroid plexus epithelial cells in vitro is improved in serum-free medium. J Neurochem 1998; 71(3): 1141-50.
30. Kitada M, Chakrabortty S, Matsumoto N, Taketomi M, Ide C. Differentiation of choroid plexus ependymal cells into astrocytesafter grafting into the pre-lesioned spinal cord in mice. Glia 2001; 36(3): 364-74.
31. Wilson MR, Preston JE, Thomas SA, Segal MB. Altered cerebrospinalfluid secretion rate and 125I-labelled II-amyloid transport inthe aged sheep isolated perfused choroid plexus. J Physiol 1999; 515P: 7-8P.
32. Serot JM, Foliguet B, Bene MC, Faure GC. Choroid plexus andageing in rats: a morphometric and ultrastructural study. Eur J Neurosci 2001; 14(5): 794-8.
33. Sturrock RR. An ultrastructural study of the choroid plexus of agedmice. Anat Anz 1988; 165(5): 379-85.
34. Serot JM, Bene MC, Foliguet B, Faure GC. Morphological alterationsof the choroid plexus in late-onset Alzheimer's disease. ActaNeuropathol 2000; 99(2): 105-8.
35. Wen GY, Wisniewski HM, Kascsak RJ. Biondi ring tangles in thechoroid plexus of Alzheimer's disease and normal aging brains: aquantitative study. Brain Res 1999; 832(1-2): 40-6.
36. Shuangshoti S, Netsky MG. Human choroid plexus: morphologicand histochemical alterations with age. Am J Anat 1970; 128(1): 73-95.
37. Cottrell DA, Blakely EL, Johnson MA, Ince PG, Borthwick GM, Turnbull DM. Cytochrome c oxidase deficient cells accumulate inthe hippocampus and choroid plexus with age. Neurobiol Aging 2001; 22(2): 265-72.
38. Cottrell DA, Turnbull DM. Mitochondria and ageing. Curr OpinClin Nutr Metab Care 2000; 3(6): 473-8.
39. May C, Kaye JA, Atack JR, Schapiro MB, Friedland RP, RapoportSI. Cerebrospinal fluid production is reduced in healthy aging. Neurology 1990; 40(3 Pt 1): 500-3.
40. Tanna NK, Kohn MI, Horwich DN, Jolles PR, Zimmerman RA, Alves WM, et al. Analysis of brain and cerebrospinal fluid volumeswith MR imaging: impact on PET data correction for atrophy. PartII. Aging and Alzheimer dementia. Radiology 1991; 178(1): 123-30.
41. Miklossy J, Kraftsik R, Pillevuit O, Lepori D, Genton C, Bosman FT. Curly fiber and tangle-like inclusions in the ependyma andchoroid plexus--a pathogenetic relationship with the cortical Alzheimer-type changes? J Neuropathol Exp Neurol 1998; 57(12): 1202-12.
42. Serot JM, Bene MC, Faure GC. Comparative immunohistochemicalcharacteristics of human choroid plexus in vascular and Alzheimer'sdementia. Hum Pathol 1994; 25(11): 1185-90.
43. Brusa G, Claudiani F, Piccardo A, Pizio N, Stoehr R. Scinticisternographyin presenile and senile degenerative disease. Ital J NeurolSci 1990; 11(1): 43-7.
44. Serot JM, Bertrand A, Penin F, Hocquard C, Mietkiewicz MC, Cunt C. La cysternographie isotopique dans les détériorations mentaleset les démences du sujet âgé. Med Hyg 1987; 36: 1928-30.
45. Silverberg GD, Heit G, Huhn S, Jaffe RA, Chang SD, Bronte-Stewart H, et al. The cerebrospinal fluid production rate is reducedin dementia of the Alzheimer's type. Neurology 2001; 57(10): 1763-6.
46. Atack JR, Rapoport SI, Schapiro MB. Cerebrospinal fluid productionis normal in Down syndrome. Neurobiol Aging 1998; 19(4): 307-9.
47. Ikeda T, Furukawa Y, Mashimoto S, Takahashi K, Yamada M. Vitamin B12 levels in serum and cerebrospinal fluid of people withAlzheimer's disease. Acta Psychiatr Scand 1990; 82(4): 327-9.
48. Serot JM, Barbe F, Arning E, Bottiglieri T, Franck P, Montagne P, et al. Homocysteine and methylmalonic acid concentrations incerebrospinal fluid: relation with age and Alzheimer's disease. JNeurol Neurosurg Psychiatry 2005; 76(11): 1585-7.
49. Selley ML, Close DR, Stern SE. The effect of increased concentrationsof homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer'sdisease. Neurobiol Aging 2002; 23(3): 383-8.
50. Tohgi H, Abe T, Nakanishi M, Hamato F, Sasaki K, Takahashi S. Concentrations of alpha-tocopherol and its quinone derivative incerebrospinal fluid from patients with vascular dementia of theBinswanger type and Alzheimer type dementia. Neurosci Lett 1994; 174(1): 73-6.
51. Schippling S, Kontush A, Arlt S, Buhmann C, Sturenburg HJ, Mann U, et al. Increased lipoprotein oxidation in Alzheimer's disease. Free Radic Biol Med 2000; 28(3): 351-60.
52. Lovell MA, Gabbita SP, Markesbery WR. Increased DNA oxidationand decreased levels of repair products in Alzheimer's diseaseventricular CSF. J Neurochem 1999; 72(2): 771-6.
53. Vitek MP, Bhattacharya K, Glendening JM, Stopa E, Vlassara H, Bucala R, et al. Advanced glycation end products contribute toamyloidosis in Alzheimer disease. Proc Natl Acad Sci USA 1994; 91(11): 4766-70.
54. Smith MA, Tabaton M, Perry G. Early contribution of oxidativeglycation in Alzheimer disease. Neurosci Lett 1996; 217(2-3): 210-1.
55. Troncoso JC, Costello A, Watson AL, Jr., Johnson GV. In vitropolymerization of oxidized tau into filaments. Brain Res 1993; 613(2): 313-6.
56. Münch G, Schinzel R, Loske C, Wong A, Durany N, Li JJ, et al. Alzheimer's disease--synergistic effects of glucose deficit, oxidativestress and advanced glycation endproducts. J Neural Transm 1998; 105(4-5): 439-61.
57. Shuvaev VV, Laffont I, Serot JM, Fujii J, Taniguchi N, Siest G. Increased protein glycation in cerebrospinal fluid of Alzheimer'sdisease. Neurobiol Aging 2001; 22(3): 397-402.
58. Vargas T, Ugalde C, Spuch C, Antequera D, Moran MJ, Martin MA, et al. Abeta accumulation in choroid plexus is associated withmitochondrial-induced apoptosis. Neurobiol Aging 2008 [Epubahead of print].
59. Perez-Gracia E, Blanco R, Carmona M, Carro E, Ferrer I. Oxidativestress damage and oxidative stress responses in the choroidplexus in Alzheimer's disease. Acta Neuropathol 2009; 118(4): 497-504.
60. Tanzi RE, Bertram L. Twenty years of the Alzheimer's diseaseamyloid hypothesis: a genetic perspective. Cell 2005; 120(4): 545-55.
61. Selkoe DJ. Alzheimer's disease results from the cerebral accumulationand cytotoxicity of amyloid beta-protein. J Alzheimers Dis 2001; 3(1): 75-80.
62. Holtzman DM. Pittsburgh compound B retention and verificationof amyloid deposition. Arch Neurol 2007; 64(3): 315-6.
63. Deane R, Du Yan S, Submamaryan RK, LaRue B, Jovanovic S, Hogg E, et al. RAGE mediates amyloid-beta peptide transportacross the blood-brain barrier and accumulation in brain. Nat Med 2003; 9(7): 907-13.
64. Deane R, Wu Z, Sagare A, Davis J, Du Yan S, Hamm K, et al. LRP/amyloid beta-peptide interaction mediates differential brainefflux of Abeta isoforms. Neuron 2004; 43(3): 333-44.
65. Bell RD, Sagare AP, Friedman AE, Bedi GS, Holtzman DM, Deane R, et al. Transport pathways for clearance of human Alzheimer'samyloid beta-peptide and apolipoproteins E and J in themouse central nervous system. J Cereb Blood Flow Metab 2007; 27(5): 909-18.
66. Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, et al. Clearance of Alzheimer's amyloid-ss(1-40) peptide frombrain by LDL receptor-related protein-1 at the blood-brain barrier. JClin Invest 2000; 106(12): 1489-99.
67. Carro E, Trejo JL, Gomez-Isla T, LeRoith D, Torres-Aleman I. Serum insulin-like growth factor I regulates brain amyloid-betalevels. Nat Med 2002; 8(12): 1390-7.
68. Crossgrove JS, Li GJ, Zheng W. The choroid plexus removes betaamyloidfrom brain cerebrospinal fluid. Exp Biol Med (Maywood)2005; 230(10): 771-6.
69. Silverberg GD, Mayo M, Saul T, Rubenstein E, McGuire D. Alzheimer'sdisease, normal-pressure hydrocephalus, and senescentchanges in CSF circulatory physiology: a hypothesis. Lancet Neurol 2003; 2(8): 506-11.
70. Strazielle N, Ghersi-Egea JF. Demonstration of a coupled metabolism-efflux process at the choroid plexus as a mechanism of brainprotection toward xenobiotics. J Neurosci 1999; 19(15): 6275-89.
71. Zheng W, Zhao Q. The blood-CSF barrier in culture. Developmentof a primary culture and transepithelial transport model from choroidalepithelial cells. Methods Mol Biol 2002; 188: 99-114.
72. Chun JT, Wang L, Pasinetti GM, Finch CE, Zlokovic BV. Glycoprotein330/megalin (LRP-2) has low prevalence as mRNA andprotein in brain microvessels and choroid plexus. Exp Neurol 1999; 157(1): 194-201.
73. Carro E, Torres-Aleman I. The role of insulin and insulin-likegrowth factor I in the molecular and cellular mechanisms underlyingthe pathology of Alzheimer's disease. Eur J Pharmacol 2004; 490(1-3): 127-33.
74. Marinò M, Chiovato L, Lisi S, Pinchera A, McCluskey RT. Phosphoinositide3-kinase inhibits megalin-mediated transcytosis of thyroglobulinacross thyroid epithelial cells at a post-sorting level. EurJ Endocrinol 2001; 145(4): 477-83.
75. Kozyraki R, Fyfe J, Verroust PJ, Jacobsen C, Dautry-Varsat A, Gburek J, et al. Megalin-dependent cubilin-mediated endocytosis isa major pathway for the apical uptake of transferrin in polarizedepithelia. Proc Natl Acad Sci USA 2001; 98(22): 12491-6.
76. DeMattos RB, Bales KR, Cummins DJ, Dodart JC, Paul SM, Holtzman DM. Peripheral anti-A beta antibody alters CNS andplasma A beta clearance and decreases brain A beta burden in amouse model of Alzheimer's disease. Proc Natl Acad Sci USA2001; 98(15): 8850-5.
77. Banks WA, Robinson SM, Verma S, Morley JE. Efflux of humanand mouse amyloid beta proteins 1-40 and 1-42 from brain: impairmentin a mouse model of Alzheimer's disease. Neuroscience 2003; 121(2): 487-92.
78. Ghersi-Egea JF, Gorevic PD, Ghiso J, Frangione B, Patlak CS, Fenstermacher JD. Fate of cerebrospinal fluid-borne amyloid betapeptide:rapid clearance into blood and appreciable accumulationby cerebral arteries. J Neurochem 1996; 67(2): 880-3.
79. Dietrich MO, Spuch C, Antequera D, Rodal I, de Yebenes JG, Molina JA, et al. Megalin mediates the transport of leptin acrossthe blood-CSF barrier. Neurobiol Aging 2008; 29(6): 902-12.
80. Jaeger S, Pietrzik CU. Functional role of lipoprotein receptors inAlzheimer's disease. Curr Alzheimer Res 2008; 5(1): 15-25.
81. May P, Woldt E, Matz RL, Boucher P. The LDL receptor-relatedprotein (LRP) family: an old family of proteins with new physiologicalfunctions. Ann Med 2007; 39(3): 219-28.
82. Hjälm G, Murray E, Crumley G, Harazim W, Lundgren S, Onyango I, et al. Cloning and sequencing of human gp330, a Ca(2+)-binding receptor with potential intracellular signaling properties. Eur J Biochem 1996; 239(1): 132-7.
83. Saito A, Pietromonaco S, Loo AK, Farquhar MG. Complete cloningand sequencing of rat gp330/"megalin," a distinctive member ofthe low density lipoprotein receptor gene family. Proc Natl AcadSci USA 1994; 91(21): 9725-9.
84. Christensen EI, Birn H. Megalin and cubilin: multifunctionalendocytic receptors. Nat Rev Mol Cell Biol 2002; 3(4): 256-66.
85. Müller D, Nykjaer A, Willnow TE. From holoprosencephaly toosteopathology: role of multifunctional endocytic receptors in absorptiveepithelia. Ann Med 2003; 35(5): 290-9.
86. Argraves WS, Morales CR. Immunolocalization of cubilin, megalin, apolipoprotein J, and apolipoprotein A-I in the uterus andoviduct. Mol Reprod Dev 2004; 69(4): 419-27.
87. Moestrup SK, Verroust PJ. Megalin- and cubilin-mediated endocytosisof protein-bound vitamins, lipids, and hormones in polarizedepithelia. Annu Rev Nutr 2001; 21: 407-28.
88. Van Praet O, Argraves WS, Morales CR. Co-expression and interactionof cubilin and megalin in the adult male rat reproductive system. Mol Reprod Dev 2003; 64(2): 129-35.
89. Yammani RR, Seetharam S, Seetharam B. Cubilin and megalinexpression and their interaction in the rat intestine: effect of thyroidectomy. Am J Physiol Endocrinol Metab 2001; 281(5): E900-7.
90. Kounnas MZ, Haudenschild CC, Strickland DK, Argraves WS. Immunological localization of glycoprotein 330, low density lipoproteinreceptor related protein and 39 kDa receptor associated proteinin embryonic mouse tissues. In Vivo 1994; 8(3): 343-51.
91. Wicher G, Larsson M, Rask L, Aldskogius H. Low-density lipoproteinreceptor-related protein (LRP)-2/megalin is transiently expressedin a subpopulation of neural progenitors in the embryonicmouse spinal cord. J Comp Neurol 2005; 492(2): 123-31.
92. Wicher G, Larsson M, Fex Svenningsen A, Gyllencreutz E, Rask L, Aldskogius H. Low density lipoprotein receptor-related protein-2/megalin is expressed in oligodendrocytes in the mouse spinalcord white matter. J Neurosci Res 2006; 83(5): 864-73.
93. Bento-Abreu A, Velasco A, Polo-Hernández E, Párez-Reyes PL, Tabernero A, Medina JM. Megalin is a receptor for albumin in astrocytesand is required for the synthesis of the neurotrophic factoroleic acid. J Neurochem 2008; 106(3): 1149-59.
94. Ambjørn M, Asmussen JW, Lindstam M, Gotfryd K, Jacobsen C, Kiselyov VV, et al. Metallothionein and a peptide modeled aftermetallothionein, EmtinB, induce neuronal differentiation and survivalthrough binding to receptors of the low-density lipoproteinreceptor family. J Neurochem 2008; 104(1): 21-37.
95. LaFerla FM, Troncoso JC, Strickland DK, Kawas CH, Jay G. Neuronal cell death in Alzheimer's disease correlates with apoE uptakeand intracellular Abeta stabilization. J Clin Invest 1997; 100(2): 310-20.
96. Chung NS, Wasan KM. Potential role of the low-density lipoproteinreceptor family as mediators of cellular drug uptake. Adv DrugDeliv Rev 2004; 56(9): 1315-34.
97. Biemesderfer D. Regulated intramembrane proteolysis of megalin:linking urinary protein and gene regulation in proximal tubule? Kidney Int 2006; 69(10): 1717-21.
98. May P, Bock HH, Herz J. Integration of endocytosis and signaltransduction by lipoprotein receptors. Sci STKE 2003; 2003(176): PE12.
99. Bonifacino JS, Traub LM. Signals for sorting of transmembraneproteins to endosomes and lysosomes. Annu Rev Biochem 2003; 72: 395-447.
100. Borlongan CV, Skinner SJ, Geaney M, Vasconcellos AV, Elliott RB, Emerich DF. CNS grafts of rat choroid plexus protect againstcerebral ischemia in adult rats. Neuroreport 2004; 15(10): 1543-7.
101. Borlongan CV, Skinner SJ, Geaney M, Vasconcellos AV, Elliott RB, Emerich DF. Neuroprotection by encapsulated choroid plexusin a rodent model of Huntington's disease. Neuroreport 2004; 15(16): 2521-5.
102. Emerich DF, Skinner SJ, Borlongan CV, Vasconcellos AV, Thanos CG. The choroid plexus in the rise, fall and repair of the brain. Bioessays 2005; 27(3): 262-74.